ZA200708811B - Use of a sulfonamide compound for improving the pharma-cokinetics of a drug - Google Patents
Use of a sulfonamide compound for improving the pharma-cokinetics of a drugInfo
- Publication number
- ZA200708811B ZA200708811B ZA200708811A ZA200708811A ZA200708811B ZA 200708811 B ZA200708811 B ZA 200708811B ZA 200708811 A ZA200708811 A ZA 200708811A ZA 200708811 A ZA200708811 A ZA 200708811A ZA 200708811 B ZA200708811 B ZA 200708811B
- Authority
- ZA
- South Africa
- Prior art keywords
- cokinetics
- pharma
- drug
- improving
- sulfonamide compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05103035 | 2005-04-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200708811B true ZA200708811B (en) | 2009-01-28 |
Family
ID=35589560
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200708811A ZA200708811B (en) | 2005-04-15 | 2007-10-12 | Use of a sulfonamide compound for improving the pharma-cokinetics of a drug |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US8557854B2 (en) |
| EP (1) | EP1874307A2 (en) |
| JP (1) | JP2008535896A (en) |
| CN (1) | CN101175491B (en) |
| AR (1) | AR053845A1 (en) |
| AU (1) | AU2006234335B2 (en) |
| BR (1) | BRPI0608322A2 (en) |
| CA (1) | CA2604799C (en) |
| EA (1) | EA016340B1 (en) |
| TW (1) | TW200745100A (en) |
| WO (1) | WO2006108879A2 (en) |
| ZA (1) | ZA200708811B (en) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10027887A1 (en) | 2000-05-31 | 2001-12-13 | Jenapharm Gmbh | Compounds with a sulfonamide group and pharmaceutical compositions containing these compounds |
| US7534780B2 (en) | 2004-05-21 | 2009-05-19 | Bayer Schering Pharma Aktiengesellschaft | Estradiol prodrugs |
| DE102005057421A1 (en) * | 2005-11-30 | 2007-05-31 | Bayer Schering Pharma Ag | New heteroaromatic sulfonamide prodrugs, useful for delivering e.g. antimalarials and steroids for e.g. fertility control or hormone replacement therapy |
| EP2134336B1 (en) | 2007-03-16 | 2013-12-11 | Sequoia Pharmaceuticals | Benzofuran-derived hiv protease inhibitors |
| AR069539A1 (en) * | 2007-07-25 | 2010-02-03 | Tibotec Pharm Ltd | ADVANCES REGARDING FORMULATIONS OF TABLETS AGAINST HIV |
| CN101965186A (en) * | 2007-11-28 | 2011-02-02 | 塞阔伊亚药品公司 | Compositions and methods for inhibiting cytochrome p450 2d6 |
| UA103013C2 (en) * | 2007-12-06 | 2013-09-10 | Тиботек Фармасьютикелз | Amide compounds as boosters of antivirals |
| AU2008346823B2 (en) * | 2008-01-04 | 2015-03-12 | Gilead Sciences, Inc. | Inhibitors of cytochrome P450 |
| US20110195940A1 (en) * | 2008-09-17 | 2011-08-11 | Nektar Therapeutics | Protease Inhibitors Having Enhanced Features |
| BRPI0920809A2 (en) * | 2008-10-07 | 2016-07-12 | Tibotec Pharm Ltd | amide compounds as antiviral boosters |
| US8921415B2 (en) | 2009-01-29 | 2014-12-30 | Mapi Pharma Ltd. | Polymorphs of darunavir |
| US20110155359A1 (en) * | 2009-12-16 | 2011-06-30 | E. I. Du Pont De Nemours And Company | Hollow structures and associated method for conveying refrigerant fluids |
| CA2784398A1 (en) | 2010-01-28 | 2011-08-04 | Mapi Pharma Limited | Process for the preparation of darunavir and darunavir intermediates |
| AR080375A1 (en) | 2010-03-05 | 2012-04-04 | Sanofi Aventis | PROCEDURE FOR THE PREPARATION OF 2- (CYCLOHEXIMETHYL) -N- {2 - [(2S) -1-METHYLPIRROLIDIN-2-IL] ETIL} -1,2,3,4-TETRAHYDROISOCHINOLINE- 7-SULFONAMIDE |
| CN102080122B (en) * | 2010-11-26 | 2013-04-10 | 吉林大学 | Detecting method for simultaneously measuring metabolic products of probe medicines of five CYP450 enzymes |
| CN102175804B (en) * | 2010-12-30 | 2013-06-05 | 吉林大学 | Absolute quantitative method for biomass spectra of CYP450 enzyme hypotypes |
| CN104540813A (en) * | 2012-06-27 | 2015-04-22 | 默沙东公司 | Sulfonamide derivatives and methods of use thereof for improving the pharmacokinetics of a drug |
| WO2014000178A1 (en) | 2012-06-27 | 2014-01-03 | Merck Sharp & Dohme Corp. | Sulfonamide derivatives and methods of use thereof for improving the pharmacokinetics of a drug |
| WO2014194519A1 (en) | 2013-06-07 | 2014-12-11 | Merck Sharp & Dohme Corp. | Imidazole derivatives and methods of use thereof for improving pharmacokinetics of drug |
| WO2015070367A1 (en) | 2013-11-12 | 2015-05-21 | Merck Sharp & Dohme Corp. | Piperidine or piperazine linked imidazole and triazole derivatives and methods of use thereof for improving the pharmacokinetics of a drug |
| WO2015070366A1 (en) | 2013-11-12 | 2015-05-21 | Merck Sharp & Dohme Corp. | Aryl linked imidazole and triazole derivatives and methods of use thereof for improving the pharmacokinetics of a drug |
| CN111202723A (en) * | 2020-02-15 | 2020-05-29 | 江苏艾立康药业股份有限公司 | Darunavir inhalation dry powder pharmaceutical composition and preparation method thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6037157A (en) * | 1995-06-29 | 2000-03-14 | Abbott Laboratories | Method for improving pharmacokinetics |
| US6436989B1 (en) | 1997-12-24 | 2002-08-20 | Vertex Pharmaceuticals, Incorporated | Prodrugs of aspartyl protease inhibitors |
| AU2012199A (en) | 1997-12-24 | 1999-07-19 | Vertex Pharmaceuticals Incorporated | Prodrugs of aspartyl protease inhibitors |
| AU2010299A (en) | 1997-12-24 | 1999-07-19 | Vertex Pharmaceuticals Incorporated | Prodrugs os aspartyl protease inhibitors |
| ATE343567T1 (en) | 2001-02-14 | 2006-11-15 | Tibotec Pharm Ltd | BROAD SPECTRUM 2-(SUBSTITUTED-AMINO)-BENZOTHIAZOLE SULFONAMIDE HIV PROTEASE INHIBITORS |
| AU2002310818B2 (en) * | 2001-05-11 | 2007-12-13 | Tibotec Pharmaceuticals Ltd. | Broadspectrum 2-amino-benzoxazole sulfonamide HIV protease inhibitors |
| EP1304404A1 (en) | 2001-10-17 | 2003-04-23 | Milliken Europe N.V. | Reinforcement fabrics having at least two reinforcement directions |
| AR037797A1 (en) * | 2001-12-12 | 2004-12-01 | Tibotec Pharm Ltd | COMBINATION OF PROTEASA INHIBITORS DEPENDENTS OF CITOCROMO P450 |
| AU2003231766A1 (en) | 2002-04-26 | 2003-11-10 | Gilead Sciences, Inc. | Non nucleoside reverse transcriptase inhibitors |
| BRPI0414916A (en) * | 2003-09-30 | 2006-11-07 | Tibotec Pharm Ltd | methods for the preparation of benzoxazole sulfonamide compounds and intermediates thereof |
-
2006
- 2006-04-12 AR ARP060101466A patent/AR053845A1/en not_active Application Discontinuation
- 2006-04-14 EP EP06754743A patent/EP1874307A2/en not_active Withdrawn
- 2006-04-14 WO PCT/EP2006/061614 patent/WO2006108879A2/en active Application Filing
- 2006-04-14 CN CN2006800125424A patent/CN101175491B/en not_active Expired - Fee Related
- 2006-04-14 BR BRPI0608322-6A patent/BRPI0608322A2/en not_active IP Right Cessation
- 2006-04-14 JP JP2008505907A patent/JP2008535896A/en not_active Ceased
- 2006-04-14 AU AU2006234335A patent/AU2006234335B2/en not_active Ceased
- 2006-04-14 EA EA200702242A patent/EA016340B1/en not_active IP Right Cessation
- 2006-04-14 US US11/911,465 patent/US8557854B2/en not_active Expired - Fee Related
- 2006-04-14 CA CA2604799A patent/CA2604799C/en not_active Expired - Fee Related
- 2006-04-14 TW TW095113311A patent/TW200745100A/en unknown
-
2007
- 2007-10-12 ZA ZA200708811A patent/ZA200708811B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006108879A2 (en) | 2006-10-19 |
| JP2008535896A (en) | 2008-09-04 |
| CN101175491A (en) | 2008-05-07 |
| EP1874307A2 (en) | 2008-01-09 |
| AR053845A1 (en) | 2007-05-23 |
| TW200745100A (en) | 2007-12-16 |
| CA2604799A1 (en) | 2006-10-19 |
| BRPI0608322A2 (en) | 2009-12-29 |
| EA200702242A1 (en) | 2008-02-28 |
| US8557854B2 (en) | 2013-10-15 |
| US20080287488A1 (en) | 2008-11-20 |
| CN101175491B (en) | 2011-07-27 |
| AU2006234335A1 (en) | 2006-10-19 |
| AU2006234335B2 (en) | 2011-09-29 |
| CA2604799C (en) | 2015-06-09 |
| WO2006108879A3 (en) | 2008-01-10 |
| EA016340B1 (en) | 2012-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200708811B (en) | Use of a sulfonamide compound for improving the pharma-cokinetics of a drug | |
| EP1932841A4 (en) | Sulfonamide compound | |
| GB0501999D0 (en) | Pharmaceutical compounds | |
| GB0520657D0 (en) | Pharmaceutical compounds | |
| GB0520656D0 (en) | Pharmaceutical compounds | |
| IL182149A0 (en) | Sulfonamide compounds | |
| EP1909576A4 (en) | Novel pharmaceutical compounds | |
| GB0504995D0 (en) | Use of a compound | |
| ZA200800368B (en) | New pharmaceutical compounds | |
| IL181229A0 (en) | Noncardiotoxic pharmaceutical compounds | |
| GB0512643D0 (en) | Pharmaceutical compounds | |
| ZA200705612B (en) | Pharmaceutical compounds | |
| GB0501475D0 (en) | Pharmaceutical compounds | |
| GB0428554D0 (en) | Pharmaceutical compounds | |
| GB0424742D0 (en) | Pharmaceutical compounds | |
| GB0522829D0 (en) | Use of a compound | |
| GB0516167D0 (en) | Pharmaceutical compounds | |
| GB0526607D0 (en) | Pharmaceutical compounds | |
| GB0501480D0 (en) | Pharmaceutical compounds | |
| GB0512654D0 (en) | Pharmaceutical compounds | |
| GB0512681D0 (en) | Pharmaceutical compounds | |
| GB0501310D0 (en) | Pharmaceutical compounds | |
| GB0516790D0 (en) | Pharmaceutical compounds | |
| GB0507474D0 (en) | Pharmaceutical compounds | |
| GB0502055D0 (en) | Pharmaceutical compounds |